What constitutes cerebral palsy in the twenty-first century?

Developmental Medicine and Child Neurology

Volumn 56, Issue 4, 2014, Pages 323-328

  Smithers Sheedy, Hayley ^a,b,c   Badawi, Nadia ^a,b,c,d   Blair, Eve ^e   Cans, Christine ^f   Himmelmann, Kate ^g   Krägeloh Mann, Ingeborg ^h   Mcintyre, Sarah ^a,c   Slee, Jennie ⁱ   Uldall, Peter ^j   Watson, Linda ^e,k   Wilson, Meredith ^d,l  

^a Cerebral Palsy Alliance Research Institute   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NOTRE DAME   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^h UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁱ KING EDWARD MEMORIAL HOSPITAL   (Australia)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k DEPARTMENT OF HEALTH   (Australia)

^l UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; BRAIN INJURY; CEREBRAL PALSY; CONSENSUS; DECISION TREE; DISEASE COURSE; DISEASE SURVEILLANCE; HUMAN; METABOLIC DISORDER; MOTOR PERFORMANCE; PRIORITY JOURNAL; REGISTER; REVIEW; SURVIVAL;

CEREBRAL PALSY; EUROPE; HISTORY, 20TH CENTURY; HUMANS; POPULATION SURVEILLANCE;

EID: 84896085070     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12262     Document Type: Review

References (34)

1. Badawi N, Watson L, Petterson B, et al. What constitutes cerebral palsy? Dev Med Child Neurol 1998; 40: 520-7.
2. Boyd R, McIntyre S, Novak I. Abstracts of the third international cerebral palsy conference. 18-21 February 2009, Sydney, Australia. Dev Med Child Neurol 2009; 51: 1-91.
3. The Antenatal Magnesium Sulphate for Neuroprotection Guideline Development Panel. Antenatal Magnesium Sulphate Prior to Preterm Birth for Neuroprotection of the Fetus, Infant and Child: National Clinical Practice Guidelines. Adelaide: The University of Adelaide, 2010.
4. Jacobs S, Hunt R, Tarnow-Mordi W, Inder T, Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2007; CD003311.
5. Smithers-Sheedy H, McIntyre S, Watson L, Yeargin-Allsop M, Blair E, Cans C. Report of the international survey of cerebral palsy registers and surveillance systems. Cerebral Palsy Institute; 2009 Available from: http://www.cpresearch.org.au/pdfs/Report-of-the-international-survey-of-cerebral-palsy-registers-and-surveillance-systems-2009.pdf. (accessed 21 March 2013).
6. Mutch LW, Alberman E, Hagberg B, Kodama K, Velickovic MV. Cerebral palsy epidemiology: where are we now and where are we going? Dev Med Child Neurol 1992; 34: 547-55.
7. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol 2007; 49(Suppl. 109): 8-14.
8. Surveillance of cerebral palsy in Europe. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol 2000; 42: 816-24.
9. Pakula AT, Van Naarden Braun K, Yeargin-Allsopp M. Cerebral palsy: classification and epidemiology. Phys Med Rehabil Clin N Am 2009; 20: 425-52.
10. Sellier E, Horber V, Krageloh-Mann I, De La Cruz J, Cans C. Interrater reliability study of cerebral palsy diagnosis, neurological subtype, and gross motor function. Dev Med Child Neurol 2012; 54: 815-21.
11. Jethwa A, Mink J, Macarthur C, Knights S, Fehlings T, Fehlings D. Development of the Hypertonia Assessment Tool (HAT): a discriminative tool for hypertonia in children. Dev Med Child Neurol 2010; 52: e83-7.
12. Williams N, Love S, Gibson N, Blair E. Abstracts of the Third International Cerebral Palsy Conference, 18-21 February 2009, Sydney, Australia. Dev Med Child Neurol 2009; 51: 1-91.
13. Korzeniewski S, Birbeck G, DeLano M, Potchen M, Paneth N. A systematic review of neuroimaging for cerebral palsy. J Child Neurol 2008; 23: 216.
14. Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2004; 62: 851-63.
15. Towsley K, Shevell MI, Dagenais L. Population-based study of neuroimaging findings in children with cerebral palsy. Eur J Paediatr Neurol 2011; 15: 29-35.
16. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214-23.
17. Eliasson A, Krumlinde-Sundholm L, Rösbladm B, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol 2006; 48: 549-54.
18. Paneth N. Establishing the diagnosis of cerebral palsy. Clin Obstet Gynecol 2008; 51: 742-8.
19. Monavari AA, Naughten ER. Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management. Arch Dis Child 2000; 82: 67-70.
20. Hughes I, Newton R. Genetic aspects of cerebral palsy. Dev Med Child Neurol 1992; 34: 80-6.
21. Gupta R, Appleton RE. Cerebral palsy: not always what it seems. Arch Dis Child 2001; 85: 356-60.
22. Watson L, Blair E. F. S. Report of the Western Australian Cerebral Palsy Register to Birth Year 1999: Telethon, Institute for Child Health Research, 2006.
23. Surman G, Newdick H, King A, Davenport H, Kurinczuk J. 4 Child: Four Counties Database of Cerebral Palsy, Vision Loss and Hearing Loss in Children. Annual Report 2009, including data for births 1984 to 2003. Oxford: National Perinatal Epidemiology Unit, 2009, Contract No.: ISSN 1749-9674.
24. Hutton P, Pharoah P. Life expectancy in severe cerebral palsy. Arch Dis Child 2006; 91: 254-8.
25. Einspieler C, Prechtl HF, Bos AF, Ferrari F, Cioni G. Prechtl's Method on the Qualitative Assessment of General Movements in Preterm, Term and Young Infants. London: Clinics in Developmental Medicine No 167., Mac Keith Press, 2005.
26. Hadders-Algra M. General movements: a window for early identification of children at high risk for developmental disorders. J Pediatr 2004; 145: S12-18.
27. Spittle A. How do we use the assessment of general movements in clinical practice? Dev Med Child Neurol 2011; 53: 681-2.
28. Laptook A, Shankaran S, Ambalavanan N, et al. Prediction of early childhood outcome of term infants using apgar scores at 10 minutes following hypoxic-ischemic encephalopathy. Pediatrics 2009; 124: 1619.
29. Blair E, Watson L, Badawi N, Stanley FJ. Life expectancy among people with cerebral palsy in Western Australia. Dev Med Child Neurol 2001; 43: 508-15.
30. Opitz J. Association and sydnromes: terminology in clinical genetics and birth defects epidemiology: comments on Khoury Moore and Evans. Am J Med Genet 1994; 49: 14-20.
31. Moreno-De-Luca A, Helmers SL, Mao H, et al. Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet 2011; 48: 141-4.
32. Mochida GH. Genetics and biology of microcephaly and lissencephaly. Semin Pediatr Neurol 2009; 16: 120-6.
33. Menkes J, Flores-Sarnat L. Cerebral palsy due to chromosomal anomalies and continuous gene syndromes. Clin Perinatol 2006; 33: 481-501.
34. Report of the Australian Cerebral Palsy Register Birth Years 1993-2003 Dec 2009. Available from: http://www.cpregister.com/ (accessed 22 March 2013).